John Pears - Concepedia

Author

John Pears

AstraZeneca (United Kingdom)

Also Known As

J Pears, J S Pears, J. Pears, J. S. PEARS, J.S Pears, J.S. PEARS, J.S. Pears, John Pears, John S Pears, John S. Pears

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)Ninewells Hospital AstraZeneca (United States)Linköping University Hospital

About

John Pears is an author at AstraZeneca (United Kingdom) specializing in medicine, pharmacology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.1K
2	Health Sciences	3	3	240
3	Public Health	3	3	151
4	Management	1	1	42
5	Nursing	1	1	25

John Pears

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia Anders Olsson, John Pears, John McKellar, The American Journal of Cardiology Cardiovascular DiseasePharmacologyLow-density Lipoprotein CholesterolHyperlipidemiaLipoprotein Metabolism	2001	194
Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia Anders Olsson, Helge Istad, O Luurila, American Heart Journal HypertensionLipid DisorderCardiovascular DiseasePharmacologyHyperlipidemia	2002	176
Rosuvastatin-Induced Arrest in Progression of Renal Disease Donald G. Vidt, Michael D. Cressman, Susan S. Harris, Cardiology UrologyRenal FunctionProgressive DeclineCardiovascular DiseaseMedicine	2004	153
Safety of rosuvastatin James Shepherd, Donald B. Hunninghake, Evan A. Stein, The American Journal of Cardiology Drug SafetyMedicinePoisoningToxicologyPharmacotherapy	2004	133
Using controlled clinical trials to learn more about acute drug-induced liver injury Paul B. Watkins, Paul J. Seligman, John Pears, Hepatology Hepatic DisordersHepatologyLiver InjuryLiver PhysiologyPharmacology	2008	113
Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia Muriel Caslake, Grace Stewart, Stephen Day, Atherosclerosis Metabolic SyndromeAtherogenic Lipoprotein Subfractions-Independent ActionsCardiovascular DiseaseBiochemistry	2003	89
Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin Daniel J. Rader, Michael H. Davidson, Richard Caplan, The American Journal of Cardiology Metabolic SyndromeLipid DisorderCardiovascular EpidemiologyCardiovascular DiseaseMedicine	2003	84
A case study using the PrOACT‐URL and BRAT frameworks for structured benefit risk assessment Richard M. Nixon, Christoph Dierig, Shahrul Mt‐Isa, Biometrical Journal Clinical Decision-makingRiskbenefit RatioBinary ScaleRisk AnalysisPreventive Medicine	2015	42
Long-Term Weight Changes in Treated Hyperthyroid and Hypothyroid Patients John Pears, R. T. Jung, A. Gunn Scottish Medical Journal ObesityBody CompositionLong-term Weight ChangesRetrospective SurveyThyroid Disease	1990	38
A case of skin hyperpigmentation due to α-MSH hypersecretion John Pears, R. T. Jung, William A. Bartlett, British Journal of Dermatology	1992	27

Page 1